Prostate cancer Trials in Montréal, Canada
Conditions / Prostate cancer / Montréal, Canada
Prostate cancer is a medical condition with active clinical research programs worldwide.
134 total trials for this combination
Showing top 10 of 134 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00925600 | Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | COMPLETED | PHASE3 |
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | COMPLETED | PHASE3 |
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | UNKNOWN | PHASE3 |
| NCT01368588 | Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07028853 | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. | RECRUITING | — |
| NCT07028853 | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. | RECRUITING | — |
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | COMPLETED | PHASE2 |
| NCT01605227 | Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 | COMPLETED | PHASE3 |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | COMPLETED | PHASE1 |